These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 399639)

  • 21. Clinical trials in the community.
    Durant JR
    Semin Oncol; 1981 Dec; 8(4):473-7. PubMed ID: 7323820
    [No Abstract]   [Full Text] [Related]  

  • 22. Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy.
    Goldstein D; Levi JA; Woods RL; Russell J; Morgan J; Kerestes Z
    Oncology; 1989; 46(2):105-8. PubMed ID: 2652018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Legal considerations in clinical cancer research.
    Robertson JA
    Semin Oncol; 1981 Dec; 8(4):442-6. PubMed ID: 7323817
    [No Abstract]   [Full Text] [Related]  

  • 24. Food and Drug Administration requirements for approval of new anticancer drugs.
    Johnson JR; Temple R
    Cancer Treat Rep; 1985 Oct; 69(10):1155-9. PubMed ID: 4042094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized clinical trials in breast cancer: a tabular summary. Part 2: Advanced breast cancer.
    Kieser R; Conrad B
    Arch Geschwulstforsch; 1987; 57(4):323-49. PubMed ID: 3314771
    [No Abstract]   [Full Text] [Related]  

  • 26. The designs, control and pitfalls of clinical trials.
    Bramwell V
    Clin Otolaryngol Allied Sci; 1986 Dec; 11(6):397-401. PubMed ID: 3815864
    [No Abstract]   [Full Text] [Related]  

  • 27. Some benefit of concurrent chemo-radiotherapy in cancer.
    Hager T
    JAMA; 1983 Jul 22-29; 250(4):457-8. PubMed ID: 6345822
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemo- and radiotherapy of patients with different types of malignant neoplasms].
    Aliev BM
    Med Radiol (Mosk); 1986 Jun; 31(6):11-4. PubMed ID: 3523097
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trials in cancer research.
    Gehan EA
    Environ Health Perspect; 1979 Oct; 32():31-48. PubMed ID: 232043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methodological features of assessing the effectiveness of adjuvant therapy in clinical trials].
    Dvoĭrin VV
    Vopr Onkol; 1986; 32(6):18-22. PubMed ID: 3523991
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment evaluation in active control studies.
    Fleming TR
    Cancer Treat Rep; 1987 Nov; 71(11):1061-5. PubMed ID: 3119201
    [No Abstract]   [Full Text] [Related]  

  • 32. Statistical properties and use of sequential methods in randomized clinical trials when the response criterion is censored.
    Bénichou J; Chastang C
    Recent Results Cancer Res; 1988; 111():207-15. PubMed ID: 3175307
    [No Abstract]   [Full Text] [Related]  

  • 33. Breast tumours: a review of adjuvant chemotherapy trials.
    Plagne R
    Drugs Exp Clin Res; 1986; 12(1-3):135-42. PubMed ID: 3525067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current randomized trials on adjuvant chemotherapy in stages II A and II B.
    Boedefeld EA
    Prog Clin Biol Res; 1985; 203():335-7. PubMed ID: 3008180
    [No Abstract]   [Full Text] [Related]  

  • 35. Meta-analysis of randomized clinical trials in cancer.
    Buyse M
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2501-6. PubMed ID: 8279848
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial.
    Grage TB; Moss SE
    Surg Clin North Am; 1981 Dec; 61(6):1321-9. PubMed ID: 6171898
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-blind trial of metronidazole in malodorous ulcerating tumours.
    Ashford R; Plant G; Maher J; Teare L
    Lancet; 1984 Jun; 1(8388):1232-3. PubMed ID: 6144938
    [No Abstract]   [Full Text] [Related]  

  • 38. Randomized or historical control groups in cancer clinical trials: are historical controls valid?
    Gehan EA
    J Clin Oncol; 1986 Jul; 4(7):1024-5. PubMed ID: 3723163
    [No Abstract]   [Full Text] [Related]  

  • 39. Overcoming methodological weakness in dose-intense alkylating agent studies through pharmacology.
    Jones RB
    Clin Cancer Res; 2004 Jan; 10(2):413-4. PubMed ID: 14760059
    [No Abstract]   [Full Text] [Related]  

  • 40. Multi-institutional randomized clinical trials as a research method in cancer.
    Ortiz HG
    Int J Radiat Oncol Biol Phys; 1985 May; 11(5):1053-6. PubMed ID: 3988555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.